Non-Clinical CRO Solutions

Providing Solutions for all Non-Clinical and Clinical Areas

Non-clinical contract research organizations (CROs) have become an integral part of drug discovery and development to support sponsors research needs, expedite timelines and provide an extension of technical and scientific support. CMIC has worked with the top 10 global pharma companies and has been involved in more than 80% of new drug development in Japan. Our goal is to be your one-stop solution provider from drug discovery and development to commercial stage drug efficacy and safety evaluation.

CMIC Group is a fully AAALAC-accredited, non-clinical research facility that is run in compliance with GLP and GMP principles. We provide global coverage for our laboratory service offerings, with the Japan facility as one of the largest contract testing laboratories, providing capabilities and solutions in all aspects of non-clinical testing. With our strong link between Japan and our site in the U.S., we offer one-stop service solutions for both countries.

View All of CMIC's Non-Clinical CRO Solutions

Non-Clinical Studies
– Toxicity
– Safety Pharmacology
– Efficacy Pharmacology
– Genotoxicity
Bioanalysis and GLP
– Small Molecule
– Large Molecule
– Oligonucleotides
– Biomarkers
CMC and CMP Analytical Services

View CMIC’s Service Catalog >>

Our Edge in Non-Clinical CRO Services

U.S.-Japan Collaboration

With the strong collaboration between our US and Japan facilities, projects can be transferred quickly and efficiently allowing you the flexibility to work between both countries.

Global Quality Assurance System

Our quality assurance system is globally developed complying with reliability standards, GLP, and GMP for PMDA and its foreign counter-part authorities such as FDA and EMEA as well as ICH/OECD guidelines.

Major Equipment Investment

Standing by our strong commitment to providing state-of-the-art equipment/facilities to enable a wide range of testing.

Experienced Professionals Team

Led by highly specialized staff, our team consists of much experienced technicians. We fully support our clients’ development with our wide-range knowledge and diverse contract experience.

Non-clinical, Safety and Efficacy Studies

We provide pre-clinical services for IND-enabling package towards first-in-human (FIH) such as Toxicity, Genotoxicity, Safety Pharmacology, Efficacy Pharmacology studies in rodents and non-rodents as well as in-vivo Imaging studies in non-human primates (NHPs).

Non-Clinical Consulting and Medical Writing

Our staff, with experience in various fields including anti-cancer drugs and dementia medications, offer highly specialized services.

CMC and GMP Analytical Services
- Small Molecule (CMC)
- Biopharmaceuticals Analysis (CMC)
- Highly Physiological Active Drugs (CMC)
- Stability Testing
- GMP Analytical Services
- Microbial Testing
- Impurity Testing
  (Extractables & Leachables, Elemental Impurities, Nitrosamines)
Bioanalysis and GLP Analytical Services
- Small Molecule Bioanalysis
- Large Molecule Bioanalysis
- Oligonucleotides Bioanalysis
- Biomarkers
Non-clinical Studies
- Toxicity Studies
- Genotoxicity Studies
- Safety Pharmacology Studies
- Efficacy Pharmacology Studies
- In-vivo Imaging Studies in Non-Human Primates (NHPs)